Cargando…

Role of the Extracellular Matrix in the Pathogenesis of Hypertrophic Cardiomyopathy

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Marian, Ali J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712346/ https://www.ncbi.nlm.nih.gov/pubmed/31468005 http://dx.doi.org/10.1016/j.jacbts.2019.03.011

Ejemplares similares

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Detection of apical hypertrophic cardiomyopathy; which is the appropriate imaging modality
por: van der Wall, E. E., et al.
Publicado: (2008)

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
por: Walsh, R., et al.
Publicado: (2021)

JPH2 Mutant Gene Causes Familial Hypertrophic Cardiomyopathy: A Possible Model to Unravel the Subtlety of Calcium-Regulated Contractility
por: Roberts, Robert
Publicado: (2017)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
por: van der Wall, E. E.
Publicado: (2014)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Percutaneous Septal Reduction Therapy in a Patient with Severely Symptomatic Hypertrophic Obstructive Cardiomyopathy: An experience from a tertiary care centre
por: Al Lawati, Hatim, et al.
Publicado: (2022)

Better Blood Flow Delivered: Extracellular Matrix-Derived Hydrogels for the Induction of Arteriogenesis in Peripheral Artery Disease?
por: Benndorf, Ralf A.
Publicado: (2016)

The Role of Mecahnical Dyssynchrony on Functional Mitral Regurgitation in Patients with Dilated Cardiomyopathy
por: Kim, Jang-Young
Publicado: (2011)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Left Ventricular Thrombus in Hypertrophic Cardiomyopathy
por: Hamada, Mareomi
Publicado: (2018)

Genetic and Molecular Mechanisms of Hypertrophic Cardiomyopathy
por: Chou, Chun, et al.
Publicado: (2023)

Unc112: A New Regulator of Cell–Extracellular Matrix Adhesions?
por: Schaller, Michael D.
Publicado: (2000)

Cancer cells with trapped nuclei cut their way through the extracellular matrix
por: Dornier, Emmanuel, et al.
Publicado: (2018)

Emerging Therapies for Dystrophic Cardiomyopathy
por: Garry, Daniel J., et al.
Publicado: (2019)

Cell Migration through Extracellular Matrix: Membrane-Type Metalloproteinases Make the Way
por: Quaranta, Vito
Publicado: (2000)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
por: Siontis, Konstantinos C., et al.
Publicado: (2019)

To Breastfeed or Not to Breastfeed With Peripartum Cardiomyopathy
por: Arany, Zoltan, et al.
Publicado: (2019)

Paracrine Factors in Uremic Cardiomyopathy
por: Sucharov, Carmen C.
Publicado: (2020)

A maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology
por: Viola, Helena M., et al.
Publicado: (2023)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

Hypertrophic Cardiomyopathy—Current Challenges and Future Perspectives
por: Monda, Emanuele, et al.
Publicado: (2023)

Takotsubo cardiomyopathy – stunning views on the broken heart
por: Teske, A. J., et al.
Publicado: (2016)

Echocardiography in takotsubo cardiomyopathy; a useful approach?
por: van der Wall, E. E., et al.
Publicado: (2010)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy
por: Ušaj, Marko, et al.
Publicado: (2022)

Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy
por: Larson, Amy, et al.
Publicado: (2022)

Modeling Human Dilated Cardiomyopathy Using Humans
por: Gacita, Anthony M., et al.
Publicado: (2018)

Variable Morphology of Stress-Induced Cardiomyopathy
por: Ryu, Dong Ryeol
Publicado: (2013)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Profiling hypertrophic adipocytes in humans, from transcriptomics to diagnostics
por: Li, Qian, et al.
Publicado: (2022)

Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy
por: Minami, Yuichiro, et al.
Publicado: (2018)

Pathogenesis of Chagas Cardiomyopathy: Role of Inflammation and Oxidative Stress
por: Machado, Fabiana S., et al.
Publicado: (2013)

Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?
por: van der Wall, E. E.
Publicado: (2009)

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Right ventricular function in dilated cardiomyopathy: women are the stronger sex!
por: Merkus, D.
Publicado: (2015)

Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2021)

The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
por: van der Heijden, J. F., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5cgg54qco10s722a5rd2ha97ef